[Porphyria cutanea tarda in a patient presenting hepatitis C treated with imatinib].
Chraïbi
R
R
Service de dermatologie, hôpital Nord, CHU de Saint-Etienne, Saint-Etienne, France. rim.chraibi@caramail.com
Labeille
B
B
Perrot
J-L
JL
Cambazard
F
F
D001549:Benzamides; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D000068877:Imatinib Mesylate; D016898:Interferon-alpha / Q000627:therapeutic use; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D017119:Porphyria Cutanea Tarda / Q000139:chemically induced* / Q000473:pathology; D047428:Protein Kinase Inhibitors / Q000009:adverse effects; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000009:adverse effects*
D001549:Benzamides; D016898:Interferon-alpha; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases